Association of the Low-density Lipoprotein Cholesterol/High-density Lipoprotein Cholesterol Ratio with Glecaprevir-pibrentasvir Treatment

OBJECTIVE: The change in serum lipid levels by direct-acting antiviral (DAA) treatment for chronic hepatitis C varies depending on the type of DAA. How the lipid level changes induced by glecaprevir-pibrentasvir (G/P) treatment contribute to the clinical outcome remains unclear. We conducted a prosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Akutsu, Noriyuki, Sasaki, Shigeru, Matsui, Takeshi, Akashi, Hirofumi, Yonezawa, Kazuhiko, Ishigami, Keisuke, Tsujisaki, Masayuki, Isshiki, Hiroyuki, Yawata, Atsushi, Yamaoka, Satoshi, Ban, Toshihiro, Adachi, Takeya, Nakahara, Seiya, Takagi, Hideyasu, Nakachi, Kohei, Tanaka, Katsunori, Hirano, Takehiro, Yamamoto, Itaru, Kaneto, Hiroyuki, Wagatsuma, Kohei, Numata, Yasunao, Nakase, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627811/
https://www.ncbi.nlm.nih.gov/pubmed/34024854
http://dx.doi.org/10.2169/internalmedicine.7098-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627811/
https://www.ncbi.nlm.nih.gov/pubmed/34024854
http://dx.doi.org/10.2169/internalmedicine.7098-21

Ejemplares similares